ZEN Graphene Solutions, formerly called Zenyatta Ventures, is a mineral exploration and development company based in Ontario, Canada. Zen is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zen has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to the Zen, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
The latest ZEN Graphene news:
ZEN Graphene Solutions has announced a non-brokered private placement, for gross proceeds of up to CAD$2,000,000 (around USD$1.59 million).
The proceeds of this offering will be used for capital expenditures in the scale up of the production of ZEN's biocidal coating material, operating expenses at both Guelph locations, capital expenditures at the York Rd, Guelph manufacturing facility, graphene research and for general working capital.
Zen Graphene Solutions has announced an agreement reached on January 16th with TreborRx (Trebor) for application of its graphene-based coating on nitrile gloves sourced or produced by Trebor.
ZEN will provide Trebor with a distribution agreement for Canada, the USA and Mexico. Trebor agrees to use the coating on all gloves sold and will pay ZEN a royalty per glove coated, with a minimum first year guarantee of 100 million gloves.
Zen Graphene Solutions develops graphene-based potential treatment for bacterial and viral Infections
ZEN Graphene Solutions has announced that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound.
Recent testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto are said to indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms.
ZEN Graphene Solutions, in partnership with Professor Mohammad Arjmand, has announced the award of a CAD$780,000 (around USD$609,600) Alliance Grant - part from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the rest from a combination of cash and in kind contributions from ZEN).
Alliance Grants are awarded through a competitive peer review process, and this proposal, titled “Synthesis of Graphene Nanomaterials and Development of Their Multifunctional Polymer Nanocomposites”, is ZEN’s highest single monetary grant award from NSERC to date and supports NSERC’s growing interest in nanomaterials.
ZEN Graphene Solutions has announced that it has signed a three year lease with an option for another 3 years on 25,680 square feet of newly built B.1 industrial zoning space in Guelph, Ontario.
The new space will become ZEN’s manufacturing facility and corporate headquarters. Engineering work plus the purchase of the equipment required to produce ZEN’s graphene-based viricidal coating at commercial scale is reportedly ongoing. The company expects to begin initial production in Q4 2020 for incorporation into masks, other PPE and for HVAC filters and prefilters.